skip to Main Content

Musashi2 Promotes EGF-Induced EMT in Pancreatic Cancer via ZEB1-ERK/MAPK Signaling

Newsfeed image, light gray text on dark gray background
Our previous study showed Musashi2 (MSI2) promoted chemotherapy resistance and pernicious biology of pancreatic cancer (PC) by down-regulating Numb and p53.

We further explored the novel molecular mechanism involving its oncogenic role in PC development. Read more . . . 

Back To Top